Cartesian Therapeutics
RNAC
RNAC
16 hedge funds and large institutions have $105M invested in Cartesian Therapeutics in 2016 Q2 according to their latest regulatory filings, with 16 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
16
Holders Change
+16
Holders Change %
–
% of All Funds
0.43%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.05%
New
16
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
PVMCV
1
Polaris Venture Management Co V
Boston,
Massachusetts
|
$26.9M |
| 2 |
O
2
OrbiMed
New York
|
$25.8M |
| 3 |
PA
3
Perceptive Advisors
New York
|
$6.3M |
| 4 |
4
JPMorgan Chase & Co
New York
|
$4.22M |
| 5 |
5
UBS Group
Zurich,
Switzerland
|
$4.15M |
Top Sellers
No sellers this quarter
